Fundraising FoxClarus Ventures — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries.
BiotechHealthtechMedical DevicesPalo Alto, US
Ravindra Majeti(Director)Irving Weissman(Director)Eric Jensen(Executive Officer)
BoardChristopher Schaepe(Director)inJeffrey Bird(Director)Dennis Henner(Director)
Co-investorsBluebird VenturesGV (Google Ventures)Lightspeed Venture PartnersSofinnova VenturesSutter Hill VenturesWellington Management
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.